Document Detail

Successful blood pressure control with additive administration of eplerenone, an aldosterone receptor blocker, in a patient with bilateral renovascular hypertension treated with angioplasty.
MedLine Citation:
PMID:  21088349     Owner:  NLM     Status:  MEDLINE    
A 29-year-old woman with refractory hypertension who previously suffered from subarchnoid hemorrhage visited our facility. The diagnosis of renovascular hypertension due to fibromuscular dysplasia was made based on a high level of plasma renin activity (PRA) and aldosterone concentration (AC), and computed tomographic image of bilateral renal artery stenosis/obstruction. Angioplasty, which could be performed only to the left renal artery, failed to regain sufficient BP control. The addition of eplerenone, an aldosterone receptor blocker, to the conventional antihypertensive drugs successfully and safely lowered BP and preserved the renal function despite the persistence of high PRA and AC values.
Chikao Ibuki; Hiroshi Kawamata; Yoshihiko Seino; Kyoichi Mizuno
Related Documents :
16211209 - Beneficial cardiovascular actions of eplerenone in the spontaneously hypertensive rat.
6360879 - Aldosterone-binding globulin-induced hypertension in the rat. a new experimental model.
19352049 - Endothelial dysfunction is related to aldosterone excess and raised blood pressure.
10601119 - Impeded alveolar-capillary gas transfer with saline infusion in heart failure.
16156509 - Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration ...
9928749 - Impaired baroreflex function and arterial compliance in primary aldosteronism.
8177029 - Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
15213979 - Effect of pressure on electrophoretic mobility of polystyrene latex particles.
11505119 - Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimiz...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-11-15
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  49     ISSN:  1349-7235     ISO Abbreviation:  Intern. Med.     Publication Date:  2010  
Date Detail:
Created Date:  2010-11-22     Completed Date:  2011-03-23     Revised Date:  2013-11-25    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  2455-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hypertension, Renovascular / drug therapy*
Mineralocorticoid Receptor Antagonists / therapeutic use*
Remission Induction
Spironolactone / analogs & derivatives*,  therapeutic use
Reg. No./Substance:
0/Mineralocorticoid Receptor Antagonists; 27O7W4T232/Spironolactone; 6995V82D0B/eplerenone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Left main coronary artery thrombosis complicating an idiopathic retroperitoneal fibrosis in a 37-yea...
Next Document:  Rapidly progressing aneurysm of infected thoracic aorta with pseudoaneurysm formation.